CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 152 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $101,483,000 | 23.66% |
| Octagon Capital Advisors LP | 2,551,703 | $50,166,000 | 8.66% |
| Frazier Life Sciences Management, L.P. | 4,265,559 | $83,861,000 | 6.46% |
| Affinity Asset Advisors, LLC | 813,998 | $16,003,000 | 4.47% |
| Altium Capital Management LP | 525,000 | $10,322,000 | 3.78% |
| Deep Track Capital, LP | 3,000,000 | $58,980,000 | 2.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 340,389 | $6,685,000 | 2.14% |
| Vivo Capital, LLC | 872,151 | $17,146,000 | 1.89% |
| SPHERA FUNDS MANAGEMENT LTD. | 534,358 | $10,505,000 | 1.46% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,240,000 | 1.43% |